UGT1A1*28	Colorectal Cancer	UGT1A1*28	Colorectal Cancer	capecitabine + irinotecan Sensitive: B - Late Trials capecitabine + irinotecan Sensitive : B	capecitabine + irinotecan Sensitive: B - Late Trials capecitabine + irinotecan Sensitive : B
UGT1A1*28	Colorectal Cancer	UGT1A1*28	Colorectal Cancer	bevacizumab Sensitive: C2 – Inclusion Criteria bevacizumab Sensitive : C2	bevacizumab Sensitive: C2 – Inclusion Criteria bevacizumab Sensitive : C2
UGT1A1*28	Non Small Cell Lung Cancer	UGT1A1*28	Non Small Cell Lung Cancer	irinotecan Sensitive: C3 – Early Trials irinotecan Sensitive : C3	irinotecan Sensitive: C3 – Early Trials irinotecan Sensitive : C3
UGT1A1*28	Colorectal Cancer	UGT1A1*28	Colorectal Cancer	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3

UGT1A1*28

Associations